Canbiola, Inc. (CANB) Announces Addition of Smita Ohri M.D.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
143
Canbiola, Inc. (CANB) Announces Addition of Smita Ohri M.D. as Medical Advisor

HICKSVILLE, NY--(Marketwired - May 30, 2017) - Canbiola, Inc. ( OTC PINK : CANB ) announced today the company has added Smita Ohri M.D as a Medical Advisor to the company, Dr. Ohri will advise the company on new CBD-products specific to her core expertise inclusive of but not limited to hormone treatment, general health & fitness, detox, anti-aging lotions/salves and dieting supplement. Furthermore Dr. Ohri will advise the Company relative to patient testing and results as well conduct medical trials and gather real life testimonials related to the company's products.

Smita Ohri, MD is the Medical Director and owner of Forever Young Complete Healthcare & BodyLogicMD of Edison. She uses bioidentical hormone therapy and customized nutrition and fitness programs to treat the symptoms of hormonal imbalance. Symptoms can start as early as in the mid-thirties, perimenopause, menopause and andropause and may present as a lack of vitality and energy, stress, relationship problems, insomnia, mood swings, irritability, low libido, depression, night sweats, weight gain and fatigue. Dr. Ohri believes in a true partnership with her patients and spends considerable time to understand them in depth and treat their troubling symptoms. Her other interests are in practicing Aesthetics Medicine and Stem cell solutions.

Board Certifications, Associations and Training:

  • Member of BodyLogicMD a national network of highly trained physicians specializing in Natural Bioidentical Hormone Therapy.
  • Member of the American Academy for Anti-Aging Medicine
  • Extensive training in anti-aging provided by the fellowship in Anti-Aging and Regenerative Medicine
  • Member of the North American Menopause Society
  • Member of the American Academy of Family Practice
  • Member of the Society of Teachers of Family Medicine
  • Diplomate of the American Board of Family Practice & Board
  • Board Certified in Anti-Aging Medicine
  • Board Certified in Family Medicine
  • Board Certified in Obstetrics and Gynecology

Dr. Ohri states, "CBD products have been in my sightline for quite a while now but I did not find anyone to work with until I came across Canbiola and their unique product line, management team and marketing strategy. They are truly committed to helping people. I see a lot of possibilities for new product development inside my field of expertise where CBD will add benefits for my patients and others with similar symptoms and illnesses".

Mr. Marco Alfonsi, CEO of Canbiola , stated, "We aim to build a team of professionals to further develop and market current and new products based on real life expertise. Dr. Ohri has an amazing background and we are very proud to add her as our first medical advisor for the company."

About Dr. Ohri Dr. Ohri grew up in India, the land of Ayurveda -- an ancient science of self-healing encompassing diet and nutrition, lifestyle, exercise, rest and relaxation, meditation, breathing exercises and medicinal herbs. In the initial phase of her life she was intensely trained in allopathic medicine, completing two residencies in family medicine and in OB-GYN. She has now come back to her roots in Integrative Medicine practice, where she delivers personalized care to her patients by optimizing their hormones, highest grade, clean supplements-that may include herbs as well as advice on lifestyle and diet. Dr. Ohri has had tremendous success in healing her patients and putting them on track for optimal health but she sometimes struggles with achieving complete success in some patients. These patients, she believes, may have smoldering auto immune disease, poor quality of foods on the table, lack of exercise and motivation, stresses of daily life, family relationship problems etc. She was introduced to positive effects of CBD by some of her patients that were using it on their own, with great success, to reduce their aches and pains and stress levels. Something so natural, simple and a non-psychoactive plant extract appeared to be produce tremendous health benefits; better sleep, reduced aches and pains, weight loss, overall increased sense of well-being etc. with no apparent side effects! This got her interest and attention to delve deeper into the benefits of CBD, to do more research and apply her medical expertise to have input for new CBD formulations for myriad conditions she sees routinely in her practice.

About Canbiola, Inc. Canbiola, Inc . is a public company trading under symbol CANB .

Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola is in the process of developing its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states. The company has already launched several products found at www.canbiola.com .

The company also owns two technological solutions, Wrapmail (US Patent 8,572,275), which turns traditional email into a powerful marketing and branding tool, as well Prosperity Systems and the Bullseye platform of document management and compliance targeted at broker dealers, public companies, and governmental agencies providing a flawless all-in-one solution for document management, retention and compliance.

Forward looking statements and risks and uncertainties Matters discussed in this press release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price.

For more complete information regarding our business at Canbiola .

CONTACT INFORMATION Canbiola Investor Relations IR@canbiola.com Phone (516) 595-9544 http://www.canbiola.com Twitter Facebook

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Honoring Boston's Architects Changing the Game

Updated Category News Views 75

Celebrating Architecture's Influencers in Boston Every now and then, a profession needs a wake-up call. Stirring the pot, shaking the roots, call it what you will, but when folks rally together with a shared vision, change doesn't just seem possible — it's inevitable. On November 12, the Boston Society of Architects (BSA) and Architecture in Common (AiC) did just that...

Continue Reading
SOCSA: The Future of Safety in Confined Spaces?

Updated Category News Views 83

Autonomous Tech Meets Safety Regulations Some days innovation hits like a ton of bricks, and here we go again—this time with a gizmo aiming to shake up the safety game in confined spaces. Enter the SOCSA, the Self Operating Confined Space Attendant, designed by a seasoned agriculture worker who's had a ringside seat to enough OSHA rule breaches to fill a book. But ain't...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 29

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
NVIDIA Faces Legal Turbulence: CEO's Exit Sparks Chaos

Updated Category News Views 161

Jensen Huang's Sudden Exit: A Barrage of Headlines In what feels like a blow delivered by a sledgehammer, NVIDIA is rocked by the abrupt resignation of its iconic co-founder and CEO, Jensen Huang. This isn't some quiet departure into the night. Nope, it's more like a cannonball being fired into the investor lounge, leaving a wreckage for all to navigate through. Huang's...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
Sino Bio Speeds AI Drug Discovery with 4RISE Launch

Updated Category News Views 80

AI Meets Real-World Validation In the world of cutting-edge biotech, Sino Biological is turning heads with its latest move. If you're in the game of AI-driven drug discovery, their new 4RISE™ high-throughput wet-lab validation services could be the breakthrough you've been waiting for. Why? Well, the promise of AI is dazzling, but it all boils down to how fast you can...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Fluence Energy Faces Class Action: Investor Insights

Updated Category News Views 136

Investor Blues: Fluence Under the Weather If you've been keeping an eye on Fluence Energy (NASDAQ:FLNC), you're probably clutching your metaphorical pearls right now. Here's the scoop: on November 2, 2026, the stock took another nosedive—dropping nearly 9%—as the company announced that both CEO Julian Nebreda and CFO Ahmad Pasha had packed their bags. A leadership...

Continue Reading
Missoula Inventor Offers Handy Phone Solution on the Move

Updated Category News Views 83

Adjustable Convenience for the Modern Commuter When you're commuting or just lounging around, less hand strain and more comfort sounds like a no-brainer, right? Well, an inventive soul from Missoula, Montana, just might have cracked this little nut with a gizmo they're calling the COMMUTER PHONE. Imagine never having to juggle your phone during those bumpy moments on the...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 101

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading

Top 5 Most Recently Viewed Articles

R&R Real Estate Investment Trust's Strategic Capital Return

Updated Category News Views 289

R&R Real Estate Investment Trust's Strategic Capital Return R&R Real Estate Investment Trust (TSXV: RRR) has recently made headlines by announcing a one-time return of capital to its unitholders. The board of trustees has officially approved a return of capital amounting to C$0.00456 per unit. This initiative reflects the trust's commitment to enhancing unitholder value,...

Continue Reading
United Parks & Resorts Inc. Details Upcoming Earnings Call

Updated Category News Views 98

Important Announcement from United Parks & Resorts Inc. United Parks & Resorts Inc. (NYSE: PRKS) has exciting news to share regarding its forthcoming financial results. The company is set to unveil its third quarter financial performance before the stock market opens. This highly anticipated release is scheduled for early November, precisely on a Thursday. Alongside this...

Continue Reading
Sony's Legal Battle with Tencent: Allegations Over Game Copying

Updated Category News Views 287

Sony Takes Legal Action Against Tencent In a significant legal move, Sony Group Corp. Interactive Entertainment has brought accusations against Tencent Holdings ADR regarding its forthcoming game, "Light of Motiram." Sony claims that this game resembles its popular "Horizon" video game series in multiple ways, prompting a federal lawsuit. The Allegations Detailed This...

Continue Reading
Understanding Currency Fluctuations Amid Economic Changes

Updated Category News Views 157

Currency Movements: An Overview of Current Trends The Japanese yen has recently experienced significant depreciation, drawing concerns from monetary officials regarding its potential negative impacts on the economy. This decline may be attributed to various factors, including market sentiments favoring risk, amid expectations of fiscal policy shifts following statements...

Continue Reading
Emmanuel Ceysson to Dazzle at the USA International Harp Competition

Updated Category News Views 140

Emmanuel Ceysson's Upcoming Performance Acclaimed harpist Emmanuel Ceysson is set to perform at the USA International Harp Competition, showcasing his exceptional talent and deep love for music. This concert promises to be an unforgettable experience, filled with beautiful melodies and artistic expression. An Invitation to the Community The USA International Harp...

Continue Reading